CIK: 0001534261 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Jan 3, 2020
Total Value ($000): $966,300,626 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPARK THERAPEUTICS INC | 863,300 | $83,722,834 | 8.7% | $60.22 | — | COM | 84652J103 |
| — | INVITAE CORP | 3,838,388 | $73,965,737 | 7.7% | $10040.39 | — | COM | 46185L103 |
| CDXS | CODEXIS INC | 5,073,780 | $69,586,892 | 7.2% | $13.94 | +12.8% | COM | 192005106 |
| — | BLUEPRINT MEDICINES CORP | 940,000 | $69,061,800 | 7.1% | $9221.69 | — | COM | 09627Y109 |
| SRPT | SAREPTA THERAPEUTICS INC | 880,000 | $66,281,600 | 6.9% | $121.78 | -3.0% | COM | 803607100 |
| — | MYOKARDIA INC | 1,115,000 | $58,147,250 | 6.0% | $39.07 | — | COM | 62857M105 |
| — | BLUEBIRD BIO INC | 612,500 | $56,239,750 | 5.8% | $39167.43 | — | COM | 09609G100 |
| — | SAGE THERAPEUTICS INC | 400,000 | $56,116,000 | 5.8% | $89.71 | — | COM | 78667J108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 600,000 | $48,252,000 | 5.0% | $81.37 | -2.8% | COM | 02043Q107 |
| BLFS | BIOLIFE SOLUTIONS INC | 2,428,571 | $40,374,993 | 4.2% | $15.38 | +22.0% | COM | 09062W204 |
| FATE | FATE THERAPEUTICS INC | 2,550,000 | $39,601,500 | 4.1% | $4.33 | +342.9% | COM | 31189P102 |
| — | MAGENTA THERAPEUTICS INC | 3,048,121 | $31,273,721 | 3.2% | $1903.17 | — | COM | 55910K108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 935,000 | $30,294,000 | 3.1% | $52.35 | -20.9% | COM | 00847X104 |
| — | AUDENTES THERAPEUTICS INC | 860,000 | $24,157,400 | 2.5% | $26.14 | — | COM | 05070R104 |
| CDNA | CAREDX INC | 1,000,000 | $22,610,000 | 2.3% | $24.45 | +13.3% | COM | 14167L103 |
| — | GENMARK DIAGNOSTICS INC | 3,365,000 | $20,391,900 | 2.1% | $6.69 | — | COM | 372309104 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,128,075 | $19,414,171 | 2.0% | $14.86 | — | COM | 92915B106 |
| ILMN | ILLUMINA INC | 60,000 | $18,253,200 | 1.9% | $196.93 | +49.7% | COM | 452327109 |
| — | GRITSTONE ONCOLOGY INC | 1,770,000 | $15,283,950 | 1.6% | $4096.07 | — | COM | 39868T105 |
| — | HOMOLOGY MEDICINES INC | 820,000 | $14,842,000 | 1.5% | $11091.79 | — | COM | 438083107 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $14,556,000 | 1.5% | $32.45 | — | COM | 37890U108 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 463,125 | $14,310,562 | 1.5% | $44.30 | -7.9% | COM | 00650F109 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,455,000 | $13,167,750 | 1.4% | $8.80 | +27.5% | COM | 800677106 |
| ALEC | ALECTOR INC | 811,039 | $11,695,182 | 1.2% | $19.01 | -5.1% | COM | 014442107 |
| DNLI | DENALI THERAPEUTICS INC | 650,000 | $9,958,000 | 1.0% | $20.48 | -6.7% | COM | 24823R105 |
| — | CONSTELLATION PHARMCETICLS I | 1,523,960 | $9,844,782 | 1.0% | $6.31 | — | COM | 210373106 |
| EDIT | EDITAS MEDICINE INC | 415,000 | $9,437,100 | 1.0% | $29.14 | -15.0% | COM | 28106W103 |
| TWST | TWIST BIOSCIENCE CORP | 300,000 | $7,164,000 | 0.7% | $26.45 | +9.9% | COM | 90184D100 |
| FULC | FULCRUM THERAPEUTICS INC | 844,285 | $5,606,052 | 0.6% | $11.06 | 0.0% | COM | 359616109 |
| — | ORCHARD THERAPEUTICS PLC | 310,000 | $3,682,800 | 0.4% | $12560.65 | — | ADR | 68570P101 |
| — | DECIPHERA PHARMACEUTICALS IN | 100,000 | $3,394,000 | 0.4% | $33940.00 | — | COM | 24344T101 |
| — | TURNING POINT THERAPEUTICS I | 75,000 | $2,820,000 | 0.3% | $40080.00 | — | COM | 90041T108 |
| STOK | STOKE THERAPEUTICS INC | 130,000 | $2,793,700 | 0.3% | $27.21 | +2.5% | COM | 86150R107 |